Related by context. Frequent words. (Click for all words.) 63 FTY# 61 Phase 2b trial 61 LEVADEX 60 laquinimod 60 APF# 60 Marqibo 60 picoplatin 60 tolerability 59 asenapine 59 Phase 2b clinical 59 vilazodone 59 FOLOTYN 59 ACTEMRA 59 Zerenex 59 MGCD# [001] 59 lubiprostone 59 Entereg 58 LymphoStat B 58 telbivudine 58 INCB# [002] 58 tolerability profile 58 SEROQUEL 58 Clolar 58 ZYBRESTAT 58 relapsing remitting multiple sclerosis 58 efficacy endpoints 58 Phase IIa clinical 57 vandetanib 57 Ranexa 57 pralatrexate 57 eculizumab 57 pramipexole 57 Avanir 57 ADX# 57 Phase 2a 57 Phase 1b 57 linaclotide 57 sNDA 56 dasatinib 56 natalizumab 56 ferumoxytol 56 efficacy 56 Phase IIa trial 56 mipomersen 56 JANUVIA 56 dosing regimens 56 T DM1 56 Androxal 56 Dyloject 56 Fampridine SR 56 Phase 2b study 56 IMGN# 56 ISIS # 56 Phase 2a clinical 56 carfilzomib 56 indiplon 56 etanercept 56 TYSABRI 56 fidaxomicin 56 ONGLYZA 56 pharmacokinetic profile 56 pivotal Phase III 56 ambrisentan 55 belimumab 55 Ceplene 55 AP# [003] 55 ADVEXIN 55 Phase IIb clinical 55 Kuvan 55 Actemra 55 pirfenidone 55 rivaroxaban 55 davunetide 55 daclizumab 55 exenatide 55 ofatumumab 55 tamibarotene 55 budesonide 55 RG# [001] 55 Cinryze 55 ALKS 55 cutaneous T cell 55 Bronchitol 55 Phase Ib 54 Angiomax 54 Genasense 54 HspE7 54 Albuferon 54 rosuvastatin 54 Phase IIb 54 Cimzia 54 VIDAZA 54 aripiprazole 54 mg dose 54 dose limiting toxicities 54 satraplatin 54 pixantrone 54 voreloxin 54 avanafil 54 investigational drug 54 Phase IIb trial